Haemophilia: Vol 21, No 3

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Haemophilia

Journal list menu

Tools

Follow journal

Haemophilia: Volume 21, Issue 3

Download PDFs

Editorial

Transition considerations for extended half-life factor products

Review Article

Differentiating between signs of intra-articular joint bleeding and chronic arthropathy in haemophilia: a narrative review of the literature

Commentary

Switching from current factor VIII (FVIII) to longer acting FVIII concentrates – what is the real potential benefit?

Original Article

Clinical haemophilia

Recombinant full-length factor VIII (FVIII) and extended half-life FVIII products in prophylaxis – new insight provided by pharmacokinetic modelling

Commentary

Assessing options for treating haemophilia with inhibitors

Original Articles

Clinical haemophilia

Factor VIII alloantibody inhibitors: cost analysis of immune tolerance induction vs. prophylaxis and on-demand with bypass treatment

Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain

FEIBA in the treatment of acquired haemophilia A: Results from the prospective multicentre French ‘FEIBA dans l'hémophilie A acquise’ (FEIBHAC) registry

The natural history of occult or angiodysplastic gastrointestinal bleeding in von Willebrand disease

Parameters influencing FVIII pharmacokinetics in patients with severe and moderate haemophilia A

International cross-cultural validation study of the Canadian Haemophilia Outcomes: Kids’ Life Assessment Tool

Prophylaxis with FEIBA in paediatric patients with haemophilia A and inhibitors

Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two US centres

Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan

Rare bleeding disorders

Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency

Genetics

Congenital combined deficiency of coagulation factors VII and X – different genetic mechanisms

Novel characterization of a breakpoint in F8: an individualized approach to gene analysis when PCR and MLPA results contradict

Laboratory science

Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors?

Erratum

Erratum

This article corrects the following:

Thrombosis of abdominal aorta in congenital afibrinogenemia: case report and review of literature

Original Articles

Clinical haemophilia

Haemorrhagic complications with adenotonsillectomy in children and young adults with bleeding disorders

Cardiovascular disease prevalence and relevance in haemophilia: a scoping review

Real-life evidence in evaluating effectiveness of treatment in Haemophilia A with a recombinant FVIII concentrate: A non-interventional study in emerging countries

The impact of joint range of motion limitations on health-related quality of life in patients with haemophilia A: a prospective study

Von Willebrand disease

Joint bleeds in von Willebrand disease patients have significant impact on quality of life and joint integrity: a cross-sectional study

Genetics

Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII

Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency

Musculoskeletal

Ultrasound and magnetic resonance imaging of healthy paediatric ankles and knees: a baseline for comparison with haemophilic joints

Online Letters

VWD type 2N (Normandy) in two sisters

Selective angiographic embolization for recurrent elbow and knee haemarthroses in haemophilia: a retrospective case series

Prenatal diagnosis in a haemophilia carrier with triplet pregnancy

Common complications after arthroplasty in patients with haemophilia – a Chinese experience

Endovascular Abdominal Aortic Aneurysm Repair in a mild Haemophilia A Patient: a Case Report

Comment on: Khair K. Compliance, concordance and adherence: what are we talking about? Haemophilia Sept 2014;20(5):601–3.

Risk of erroneous results in carrier testing for haemophilia A without prior DNA analysis in male index patients

The spectrum of mutations in Southern Spanish patients with von Willebrand disease

Reliability, validity and evaluation of the Haemophilia Coping and Perception Test

Reliable and cost-effective approach for diagnosis of heterozygous F8/F9 large deletions by quantitative real-time PCR

A new case of bacterial endocarditis in a child with severe Haemophilia A carrying a central venous access device

Identification of two novel missense mutations causing severe factor XIII deficiency

Total ankle arthroplasty in patients with inherited bleeding disorders

Abstracts

Accepted Abstracts: 2015 Scientific Symposium of the Hemostasis and Thrombosis Research Society April 16–18, 2015 New Orleans, Louisiana

Sign up for email alerts

Tools

More from this journal